Skip to content
#06 - "Oxaliplatin versus Mitomycin C for HIPEC" episode artwork

Jun 5, 2019 22 min

#06 - "Oxaliplatin versus Mitomycin C for HIPEC"

from Clinical Papers Podcast

Com o objetivo de comparar Mitomicina C vs. Oxaliplatina na HIPEC para pacientes com Câncer Colorretal, os autores desse paper avaliaram, de modo retrospectivo, mais de 200 pacientes em termos de sobrevida. O dr. David Morris e seus colaboradores concluíram que os pacientes que receberam oxaliplatina (n=106) durante a HIPEC tiveram melhores taxas de sobrevida global (56 vs. 29m) quando comparados com os que usaram mitomicina (n=96). Interessante dizer que a sobrevida livre de doença foi igual! https://www.ncbi.nlm.nih.gov/pubmed/27780675 Quer saber mais sobre a discussão desse trabalho? Acesse o spotify ou podcast no seu smartphone, ou acesse o nosso site: www.clinicalpaperspodcast.com.br

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

#06 - "Oxaliplatin versus Mitomycin C for HIPEC"

0:00 22:12

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Clinical Papers Podcast?

This episode is 22 minutes long.

When was this Clinical Papers Podcast episode published?

This episode was published on June 5, 2019.

Can I download this Clinical Papers Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.